prevention of gi malignancy
TRANSCRIPT
![Page 1: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/1.jpg)
Prevention of GI malignancy
G N RameshPVS Memorial Hospital
Cochin
![Page 2: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/2.jpg)
![Page 3: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/3.jpg)
Schema
• Principles of prevention• H pylori and gastric cancer – should we eradicate
in all?• Barrett’s and malignancy – do we need to bother?• Hepatitis virus and liver cancers – how could we
do more?• Colonic cancers – applying guidelines to our
population • Pancreatic cancer – we know the preneoplastic
situations .. But can we prevent?
![Page 4: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/4.jpg)
Principles of prevention
• Primary – preventing the intitiation of the carcinogenic process – elimination , avoiding or neutralising the carcinogen
• Secondary – interfering with the metabolism of carcinogen or preventing it from reaching the target ( tissue DNA)
• Tertiary – preventing precancerous lesions from progressing to cancer ( surveillance)
![Page 5: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/5.jpg)
My aim
• Summary of factors that can be changed in our population to decrease and prevent GI cancers
![Page 6: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/6.jpg)
My aim
• Summary of factors that can be changed in our population to decrease and prevent GI cancers
30% of cancer deaths are due to 5 behavioral risk factors
High BMIReduced intake of fruits/vegetables
Sedentary life styleSmoking
Alcohol use
![Page 7: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/7.jpg)
Gastric cancer
![Page 8: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/8.jpg)
![Page 9: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/9.jpg)
The premalignant conditions
• Chronic atrophic gastritis• Intestinal metaplasia• H pylori• Gastric adenoma
![Page 10: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/10.jpg)
Gastric carcinogenesis: Histologic changes from normal gastric mucosa to neoplasia
![Page 11: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/11.jpg)
Two ends of a spectrum
• Proximal cancers
• GERD• Obesity
• Distal cancers
• Dietary factors• H pylori
![Page 12: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/12.jpg)
Primary prevention
• Decreased salt intake• Increased vitamin C consumption• Quit smoking• H pylori eradication – class I carcinogen –
decreased Ca by 35%
![Page 13: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/13.jpg)
![Page 14: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/14.jpg)
The metanalysis
![Page 15: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/15.jpg)
![Page 16: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/16.jpg)
![Page 17: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/17.jpg)
The final word?
• 1.8% vs 2.4% in controls• NNT – 15 for Chinese , 245 for USA ,• India?
![Page 18: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/18.jpg)
Adenocarcinoma of the Esophagus
![Page 19: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/19.jpg)
Gastroesophageal reflux/Barrett esophagus
• Association exists between gastroesophageal reflux disease (GERD) and adenocarcinoma – duration and severity.
• Does elimination of gastroesophageal reflux by surgical or medical means reduce the risk of adenocarcinoma of the esophagus ???
• RFA of Barrett esophagus with severe dysplasia may lead to eradication of both dysplasia and intestinal metaplasia and a reduced risk of disease progression
![Page 20: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/20.jpg)
• When should you ablate? HGD or early adenoca…..not metaplasia
• Does ablation reduce adenoca ? Perhaps yes• Does surgery reduce adenoca? .. Series of
Swedish reports – no!• Do we need surveillance in India? – no
evidence.
![Page 21: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/21.jpg)
Hepatitis and liver cancer
![Page 22: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/22.jpg)
Causes
• HBV and HCV – 80% of cases• Cirrhosis• Alcohol• Steatosis and diabetes• Medications/toxins• Genetic / metabolic diseases
![Page 23: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/23.jpg)
![Page 24: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/24.jpg)
The impact of vaccination on liver cancer
![Page 25: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/25.jpg)
The Taiwan experience
![Page 26: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/26.jpg)
Success of Hepatitis B vaccine
![Page 27: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/27.jpg)
Other issues
• Antivirals and the impact on carcinogenesis – not recurrence
• Improving the efficacy of screening programs• Effective modification of the modifiable
factors
![Page 28: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/28.jpg)
HCV and liver cancer
• Safe practices to prevent HCV• New age antivirals and their potential impact
on carcinogenesis
![Page 29: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/29.jpg)
NAFLD , cirrhosis and cancer
![Page 30: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/30.jpg)
Non modifiable modifiable
![Page 31: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/31.jpg)
The final word…
• We can do lots more • We aren’t doing enough.• Education and awareness are the key
![Page 32: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/32.jpg)
Colon cancer
![Page 33: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/33.jpg)
Who is at risk?
• Age -> 50 yrs ( 90% of all CRCs)• History
first degree relative ( < 55 yrs at diagnosis) doubles the risk personal h/o CRC / high risk adenomas/ovarian ca
• Others – IBD , genetic ( hereditary GI cancer) , HNPCC , FAP
![Page 34: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/34.jpg)
Factors and interventions to decrease CRC
Increased riskAlcohol – RR 1.41 > 45g/d
Smoking – RR 1.18Obesity – RR 1.45 BMI>29
Decreased riskPhysical activity 24% reduction
![Page 35: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/35.jpg)
Factors and interventions to decrease CRC
Increased riskAlcohol – RR 1.41 > 45g/d
Smoking – RR 1.18Obesity – RR 1.45 BMI>29
Decreased riskPhysical activity 24% reduction
InterventionsNSAIDsAspirin
Physical ActivityHormones – estrogen-progestin combination
High fiber, fruits , vegetables – inadequate evidenceLow fat/meat – inadequate evidence
Calcium supplementation – no evidenceStatins – insufficient evidence
![Page 36: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/36.jpg)
![Page 37: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/37.jpg)
![Page 38: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/38.jpg)
When to start?
• Average risk – 50 yrs• Moderate risk – ( Blacks , MS , abdominal
obesity ) 45 yrs• High risk – familial - earlier
![Page 39: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/39.jpg)
![Page 40: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/40.jpg)
How often after polyp detection?
• Small rectal polyps – 10 yrs• 1 or 2 small (<1 cm) with LGD – 5-10 YRS• 3 or more adenomas , > 1 cm , villous/HGD – 3 yrs• 10 or more - 3 yrs• Sessile polyps / piecemeal removal / HGD – 2-6 mos• HNPCC/FAP – more intensive
![Page 41: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/41.jpg)
How often after polyp detection?
• Small rectal polyps – 10 yrs• 1 or 2 small (<1 cm) with LGD – 5-10 YRS• 3 or more adenomas , > 1 cm , villous/HGD – 3 yrs• 10 or more - 3 yrs• Sessile polyps / piecemeal removal / HGD – 2-6 mos• HNPCC/FAP – more intensive
HOW EFFECTIVE IS IT?Prevents 85% of cases of distal CRC ; less effective for proximal CRC
26% reduction of mortality with flexible sigmoidoscopyRisk reduces with removal of polyps > 1 cm ; not proven with polyps <
1 cm
![Page 42: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/42.jpg)
Prevention of colorectal ca
• Diet, exercise, smoking, and supplements• daily aspirin may decrease the risk of
colorectal and extracolonic cancer in LS, currently the evidence is not sufficiently robust (CAPP1 , CAPP2 , CAPP3 trials)
![Page 43: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/43.jpg)
The final word….
• Guidelines well established• Putting guidelines into practice…not well
established• Awareness , education , enforcement• Whom? When ? What frequency ? For India
![Page 44: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/44.jpg)
Pancreatic cancer
![Page 45: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/45.jpg)
• Lethal• Stage at diagnosis• Lack of effective medical therapy• No effective screening methods• Primary prevention – most effective way to
reduce burden
![Page 46: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/46.jpg)
![Page 47: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/47.jpg)
19 prospective studies ; 3 meta analyses10-45% increase for every 5 BMI
Stronger association with obesity in the young ( 30-40 yrs)
? Related to pancreatic steatosisObesity and diabetes – risk cumulative
![Page 48: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/48.jpg)
Who is at risk for adenoca?
• Genetic syndromes - hereditary breast–ovarian cancer syndrome, familial atypical multiple melanoma and mole syndrome (FAMMM), PJS, LS, or other gene mutations
• Three or more relatives with pancreatic cancer
• Hereditary pancreatitis.
![Page 49: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/49.jpg)
HOW?
• Surveillance for PC should be with endoscopic ultrasound and/or MRI of the pancreas annually starting at age 50 years, or 10 years younger than the earliest age of PC in the family.
• Patients with PJS should start surveillance at age 35 years
![Page 50: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/50.jpg)
Screening tools ..and I whom?
• No guidelines• Chronic pancreatitis; hereditary
pancreatic cancer; hereditary pancreatitis
• How? MRI/EUS
![Page 51: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/51.jpg)
Jack Andraka, the Teen Prodigy of Pancreatic Cancer
A high school sophomore won the youth achievement Smithsonian American Ingenuity Award for inventing a new method to detect a
lethal cancerhe won the $75,000 grand prize at this past spring’s Intel International
Science and Engineering Fair,“Edison of our times,”
Follow us: @SmithsonianMag on Twitter
![Page 52: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/52.jpg)
Conclusions
• Sound knowledge of factors associated with GI cancer
• Interventions need to be executed• Awareness and education is the key• Common risk factors – smoking , obesity ,
diets , physical inactivity , alcohol – reduced burden by 25-40%
• HBV,HCV – another 10-15%
![Page 53: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/53.jpg)
![Page 54: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/54.jpg)
![Page 55: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/55.jpg)
![Page 56: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/56.jpg)
![Page 57: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/57.jpg)
![Page 58: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/58.jpg)
FAP
![Page 59: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/59.jpg)
Esophageal cancers • The following risk factors may increase the
risk of esophageal cancer:– Tobacco and alcohol use– Gastric reflux and Barrett esophagus
• The following protective factors may decrease the risk of esophageal cancer:– Avoiding tobacco and alcohol use– Diet– Nonsteroidal anti-inflammatory drugs– Radiofrequency ablation.
![Page 60: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/60.jpg)
• Screening for gastric and proximal small bowel tumors should be done using upper GI endoscopy including duodenoscopy starting at age 25–30 years.
• Annual thyroid screening by ultrasound should be recommended to individuals affected with FAP, MAP, and attenuated polyposis
![Page 61: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/61.jpg)
Hereditary gastric cancer
• (i) ≥2 cases of diff use gastric cancer, with at least one diagnosed at <50 years,
• (ii) ≥3 cases of documented diffuse cancer in first- or second-degree relatives independent of age of onset;
• (iii) diffuse gastric cancer diagnosed at <40 years; and• (iv) a personal or family history of diffuse gastric cancer
and lobular breast cancer with one diagnosed at <50 years should be evaluated for hereditary diffuse gastric cancer.
![Page 62: Prevention Of Gi Malignancy](https://reader037.vdocuments.us/reader037/viewer/2022110200/55c91f4abb61ebb8048b4782/html5/thumbnails/62.jpg)
Management
• (i) prophylactic gastrectomy after age 20 years (>80% risk by age 80 years);
• (ii) breast cancer surveillance in women beginning at age 35 years with annual mammography and breast MRI and clinical breast examination every 6 months,
• (iii) colonoscopy beginning at age 40 years for families that include colon cancer